Ledger.
Investor · Cambridge, MA

Gary Glick

Open Gary in the network graph →
Filings
11
SEC Form D
Connections
49
co-filers
Capital
$206.1M
across filings
Active
Jun 2016
to Sep 2025

Most-connected co-filers (49)

Nihal S. Sinha · London, United Kingdom3 sharedRishi Gupta · Cambridge, MA3 sharedBarry Rosenstein · New York, NY2 sharedRobert M. Barrack · New York, NY2 sharedAnilchandra G. Ladde · Richmond, VA2 sharedMichael L. Ivie · Richmond, VA2 sharedRalph J. Parker, Jr · Richmond, VA2 sharedMelissa Bethell · London, United Kingdom2 sharedWilliam Weatherford · Tampa, FL2 sharedAndrew Weatherford · Tampa, FL2 sharedIan Malloch · Cos Cob, CT2 sharedNeil Bioverge Funds Management, LLC Littman · San Francisco, CA2 sharedKevin Galligan · New York, NY2 sharedNicholas Godfrey · Herriman, UT2 sharedCharles M. Cocuzza · NEW YORK, NY2 sharedYedid Capital Management, LLC · Miami Beach, FL2 sharedAnna G. Miller · London, United Kingdom2 sharedDavid L. Caplan · New York, NY2 sharedMartin T. Saenz · Sarasota, FL2 sharedShawn T. Muneio · Sarasota, FL2 sharedScott Ostfeld · New York, NY2 sharedLakshyaditya S. Aithani · London, United Kingdom2 sharedMichael Aceti · Needham, MA2 sharedWarren Keens · Grand Cayman, Cayman Islands2 shared

Recent filings (11)

CHARM Therapeutics Inc.Sep 2025 · 13 co-filers$80.1MCHARM Therapeutics Inc.Sep 2025 · 13 co-filers$80.1MCHARM Therapeutics Inc.Apr 2023 · 14 co-filers$20.0MCHARM Therapeutics Inc.Jun 2022 · 14 co-filers$37.0MCHESAPEAKE PLUS FUND LLCJan 2022 · 13 co-filersJANA Strategic Investments Benchmark Fund, L.P.Jun 2021 · 12 co-filersCHESAPEAKE PLUS FUND LLCFeb 2021 · 13 co-filersJANA Strategic Investments Benchmark Fund, L.P.Jan 2021 · 12 co-filersScorpion Therapeutics, Inc.Dec 2020 · 13 co-filersScorpion Therapeutics, Inc.Dec 2020 · 13 co-filersScorpion Therapeutics, Inc.May 2020 · 3 co-filersScorpion Therapeutics, Inc.May 2020 · 3 co-filersFirst Wave Bio, Inc.Aug 2019 · 4 co-filers$5.0MFirst Wave Bio, Inc.Aug 2019 · 4 co-filers$5.0MIFM Therapeutics, Inc.Jun 2016 · 3 co-filersIFM Therapeutics, Inc.Jun 2016 · 3 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Gary in the interactive graph →